Health wearables face clearer regulatory pathways now. FDA guidance draws a critical distinction: devices and software that merely deliver information can operate without regulatory approval—the real line gets drawn when companies start claiming 'medical-grade' status. This means manufacturers have room to build and innovate, but must avoid making therapeutic or diagnostic claims unless they're willing to navigate the full FDA approval process. The boundary matters for the entire connected health ecosystem.